Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): Immune responses to Vacc-4x regions on p24 and changes in HIV reservoirs

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

    G Tapia, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, BH10-527, CH-1011 Lausanne, Switzerland.,
  • J F Højen
  • M Ökvist, Bionor Pharma AS, P.O.Box 1477 Vika, NO-0116 Oslo, Norway.,
  • R Olesen
  • S Leth
  • S K Nissen
  • D J VanBelzen, University of, Philadelphia, Pennsylvania 19104, USA., U O'Doherty, University of, Philadelphia, Pennsylvania 19104, USA., A Mørk, Bionor Pharma AS, P.O.Box 1477 Vika, NO-0116 Oslo, Norway., K Krogsgaard, Bionor Pharma AS, P.O.Box 1477 Vika, NO-0116 Oslo, Norway.,
  • O S Søgaard
  • L Østergaard
  • M Tolstrup
  • G Pantaleo, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, BH10-527, CH-1011 Lausanne, Switzerland., M A Sommerfelt, Bionor Pharma AS, P.O.Box 1477 Vika, NO-0116 Oslo, Norway. Electronic address: ms@bionorpharma.com.
OriginalsprogEngelsk
TidsskriftThe Journal of infection
ISSN0163-4453
DOI
StatusUdgivet - dec. 2017

Se relationer på Aarhus Universitet Citationsformater

ID: 118008840